Two monoclonal antibodies (MAbs) were used to learn more about the structures of Clostridium difficile toxins A and B. One of the antibodies, the PCG-4 MAb, reacted specifically with toxin A. This MAb precipitated toxin A and neutralized the enterotoxic but not the cytotoxic activity of the toxin. The site to which the antibody bound was resistant to denaturation with sodium dodecyl sulfate; however, it was destroyed by N-bromosuccinimide. Immunoblot analysis with the PCG-4 MAb revealed the presence of a large number of bands in preparations of denatured toxin A, suggesting that toxin A exists as an aggregate of smaller components. The antibody was covalently coupled to Affi-Gel 10, and the gel was used to purify toxin A from the culture filtrate of a highly toxigenic strain of C. difficile by immunoaffinity chromatography. The second antibody, the G-2 MAb, cross-reacted with toxins A and B. The cross-re.Iction was confirmed by immunoblot analysis. These results show that toxins A and B share an epitope and suggest that they have a common subunit.
analysis. These results show that toxins A and B share an epitope and suggest that they have a common subunit. The G-2 MAb did not neutralize or precipitate either toxin. The site to which the G-2 MAb bound was partially destroyed by sodium dodecyl sulfate and was resistant to oxidation with N-bromosuccinimide.
Clostridium difficile, the major causative agent of pseudomembranous colitis in humans, produces two toxins, designated toxin A and toxin B (3, 26, 27) . Both of the toxins are believed to be involved in the pathogenesis of pseudomembranous colitis. This is based on the findings that (i) both toxins are tissue damaging and lethal when injected into animals (2, 3, 17, 19, 20, 26, 27) , (ii) experimental animals must be vaccinated against both toxins to be protected against the disease (9, 15) , and (iii) both toxins are present in fecal specimens from patients with pseudomembranous colitis (14, 21) .
The toxins have been purified to homogeneity, and some of the properties of each toxin have been examined (2, 3, 15-17, 19, 26, 27) . Toxin A is a potent enterotoxin that elicits a hemorrhagic fluid response when injected into rabbit ileal loops. In addition to its enterotoxic activity, toxin A is slightly cytotoxic. Toxin B is a potent cytotoxin; subpicogram amounts are sufficient to cause rounding of tissue culture cells. The toxin is active against all mammalian cell lines tested to date. Toxins A and B do not show any significant levels of cross-reactivity when analyzed with polyclonal antibodies. Both toxins are inactivated by heat, proteases, and oxidizing agents.
Toxins A and B are large proteins; estimates of the sizes of the toxins by gel filtration and polyacrylamide gel electrophoresis (PAGE) indicate that they have a molecular weight of >300,000 (2, 3, 26) . The large size suggests that each toxin is composed of subunits. However, little is known about the quaternary structures of these toxins. Thelestam and Florin (28) proposed that each toxin contains a large hemagglutinin subunit, as well as a cytotoxic subunit, and that toxin A contains an enterotoxic subunit. Banno et al. (2) reported that each toxin may be composed of two subunits.
In this study, we used monoclonal antibodies (MAbs) to examine the structures of toxins A and B. Our results suggest that the toxins are aggregates of subunits and that they share at least one epitope. * Corresponding author.
MATERIALS AND METHODS
Protein determination. Protein was estimated with the Bio-Rad protein assay kit (Bio-Rad Laboratories, Richmond, Calif.) by the method of Bradford (5) . Bovine gamma globulin was the standard.
Bacterial strains. C. difficile VPI 10463, 11186, and 2037 were obtained from the anaerobe collection of the Department of Anaerobic Microbiology at Virginia Polytechnic Institute and State University, Blacksburg (12) . VPI 10463 produces high levels of toxins A and B, as determined by enterotoxic and tissue culture assays and by enzyme-linked immunosorbent assay (ELISA) (21) . VPI 11186 and 2037 do not produce detectable amounts of either toxin.
Preparation of toxin and culture filtrate. Culture filtrates were prepared from brain heart infusion dialysis flask cultures of C. difficile strains as previously described (26) . Toxin A was purified from culture filtrates of C. difficile VPI 10463 by sequential ammonium sulfate precipitation, batch ion-exchange chromatography, and precipitation at pH 5.6 (19) . The toxin was homogeneous by crossed immunoelectrophoresis and analytical PAGE in gradient gels. The injection of samples (5 jig/ml) into rabbit ileal loops resulted in an intense hemorrhagic fluid response (volume-to-length ratio, >1.0). The toxin had a tissue culture death dose (TCD100) of about 10 ng.
Toxin B was purified from culture filtrates by sequential ammonium sulfate precipitation, batch ion-exchange chromatography, and immunoaffinity chromatography (19) . The toxin was homogeneous by crossed immunoelectrophoresis. Analysis by PAGE showed one major and two minor bands. The gel was sliced into 1.5-mm sections, and each section was assayed for cytotoxic activity. Our findings showed that cytotoxic activity was associated with each band. The toxin had a TCD100 of 1 pg and was not enterotoxic.
Production of MAbs. One of the antibodies used in the study was the PCG-4 MAb. It was produced by using spleen cells from a mouse vaccinated with Formalin-treated culture filtrate from C.. difficile VPI 10463. Some of the characteristics of this antibody were reported previously (18) . It is an immunoglobulin G2a (IgG2a) (K isotype) which precipitates toxin A, as demonstrated by crossed immunoelectrophoresis. PCG-4 ascites was obtained as previously described (18) .
The G-2 antibody was obtained by fusing spleen cells from a mouse vaccinated with toxoid B with SP2/0 myeloma cells. Toxoid B was prepared by treating homogeneous toxin B with 0.4% Formalin for 1 h at 37 C. Hybridomas were screened for toxin antibody by the ELISA described below. The G-2 hybridoma was subcloned two times by limiting dilution (10) .
The antibody was isotyped by Ouchterlony immunodiffusion using rabbit antisera against mouse heavy and light chains (Litton Bionetics, Kensington, Md.). Ascites against the G-2 antibody was obtained by injecting hybridoma cells into pristane-treated mice.
Screening ELISA. The screening ELISA was done as previously described (18) . Briefly, the wells of microtiter plates (Immunolon type 1; Dynatech Laboratories, Inc., Alexandria, Va.) were coated with 0.5 ,ug of either homogeneous toxin A or toxin B. Samples to be tested for MAb were added, followed by the addition of goat anti-mouse IgGalkaline phosphatase conjugate (Sigma Chemical Co., St. Louis, Mo.) and Sigma 104 phosphatase substrate. The ELISA titer was expressed as the reciprocal of the highest dilution of test sample which gave an A405 in the range of 0. (ii) Neutralization of enterotoxic activity in hamsters. MAb (hybridoma supernatant or ascites) diluted in phosphatebuffered saline was added to an equal volume of toxin A. The mixtures were incubated at room temperature for 30 min. After incubation, samples (1 ml) of the mixtures were given intragastrically to hamsters pretreated with 1 M NaHCO3 as previously described (20) , and the animals were observed over 72 h. The amount of toxin A used in the assay (0.16 mg of toxin A per kg of body weight) was two lethal oral doses and was sufficient to cause diarrhea and death in Golden Syrian hamsters in the absence of neutralization by the antibody.
(iii) Neutralization of enterotoxic activity in rabbit ileal loops. Equal volumes of toxin A and MAb (hybridoma supernatant or ascites) diluted in phosphate-buffered saline were mixed, and the mixtures were incubated for 30 min at room temperature. After incubation, samples (1 ml) of each mixture were injected into ligated ileal loops in New Zealand White rabbits as previously described (17 method of Spackman et al (25) . Half-cystine was determined as cysteic acid by the performic acid oxidation method of Moore (22) . Tryptophan was determined by the spectrophotometric method of Edelhoch (7) . Analysis was done on a Beckman model 344 high-pressure liquid chromatograph with a Pickering Laboratory amino acid analysis column.
PAGE and immunoblot analysis. Analytical PAGE was done in the SDS-Tris discontinuous gel system of Laemmli (13) . For nondenaturing PAGE, toxin samples were mixed with bromphenol blue-glycerol and layered onto 3% stacking-7.5% running gels. For denaturing PAGE, toxin samples containing 2.5% SDS and 5% 2-mercaptoethanol were heated at 100°C for 2 min, mixed with bromphenol blueglycerol, and layered onto 3% stacking-7.5% running gels containing 0.1% SDS. Electrophoresis was done at 60 V at room temperature in 0.025 M Tris-0.192 M glycine buffer (pH 8.3) for nondenaturing PAGE and the same buffer containing 0.1% SDS for denaturing PAGE.
After electrophoresis, the samples were blotted onto nitrocellulose membranes by the general procedures described by other investigators (6, 11, 29 albumin, casein, and gelatin. For the assays, the microtiter wells were coated with 10-,ug/ml solutions of the proteins instead of toxin, and the binding of the antibody was detected as described for the screening ELISA. The G-2
MAb did not react with any of the proteins. (Tables 2 and 3) , or neutralization of the cytotoxic activity of toxins A and B by G-2 hybridoma supernatant or ascites.
Purification of toxin A by immunoaffinity chromatography. We examined the usefulness of the PCG-4 and G-2 antibodies for the purification of toxin from culture filtrates of C. difficile VPI 10463. Each antibody was coupled to Affi-Gel 10, and the gels were used to adsorb culture filtrate. We were unable to adsorb any significant amounts of toxins A and B with the G-2 antibody gel. However, the PCG-4 antibody gel specifically and quantitatively removed toxin A from the filtrate (Fig. 2b) . Analysis of toxin A eluted with 0.02 N NaOH-0.15 M NaCl showed a single immunoprecipitin arc by crossed immunoelectrophoresis (Fig. 2c) , indicating that the toxin was highly purified. Analysis of the biological activity of the toxin showed that it was less active than toxin A purified by sequential ammonium sulfate precipitation, batch ion-exchange chromatography, and precipitation at pH 5.6 ( Table 4 ). The yield of toxin A by the immunoaffinity method (2 to 4 mg per 100 ml of C. difficile VPI 10463 culture filtrate) was similar to the amount of toxin recovered by the precipitation and ion-exchange method. The amino acid composition of the purified toxin is shown in Table 5 .
Binding of MAbs to SDS-and N-bromosuccinimide-treated toxin. The stability of the PCG-4 and G-2 binding sites on the toxins was examined. Toxins A and B were inactivated with 1% SDS or 0.1 mM N-bromosuccinimide. Each of these treatments inactivates the biological activity of toxins A and B, indicating that the conformation of the toxin has been altered (19) . The binding of the PCG-4 antibody to toxin A was unaffected by the SDS treatment (Table 6 ). However, the antibody did not bind to toxin A treated with Nbromosuccinimide. On the other hand, the binding of the G-2 MAb was reduced by treating the toxins with SDS but not with N-bromosuccinimide.
Immunoblot analysis of toxins A and B with MAbs. When we examined our homogeneous preparations of toxins A and B by PAGE under nondenaturing conditions, we observed a single protein band for toxin A and one major and two minor cytotoxic bands for toxin B (Fig. 3a) . The toxin B bands migrated considerably faster than the toxin A band under these conditions. Immunoblot analysis showed that the PCG-4 MAb reacted strongly with toxin A but did not react with toxin B (Fig. 3b) and that the G-2 MAb reacted with both toxins (Fig. 3c) .
When we analyzed toxins A and B denatured with SDS and 2-mercaptoethanol, we observed one major band and numerous faster-migrating minor bands in each toxin preparation (Fig. 3d) . The major band in each preparation had an estimated molecular weight of 300,000. We analyzed the denatured toxin preparations by immunoblotting to determine whether the minor bands were components of the toxins. The PCG-4 MAb reacted with the major band as well as the minor bands in the toxin A preparation but did not react with toxin B (Fig. 3e) . The G-2 MAb reacted with the major band in each toxin preparation and some of the minor bands (Fig. 3f) .
We examined the possibility that the minor bands in each toxin preparation resulted from the proteolytic nicking by trace amounts of protease activity. Both toxins were treated with 1 mM phenylmethylsulfonyl fluoride, tetrasodium EDTA, and iodoacetate before denaturation to inhibit any degradation by low amounts of contaminating serine and metallo-and sulfhydryl-requiring proteases, respectively. None of these agents inhibited the appearance of the bands. We also analyzed VPI 10463 culture filtrate by immunoblotting to determine whether the minor bands were present or whether they were generated during the purification of the toxins. The analysis showed that culture filtrate gave the group of MAbs which cross-react with the toxins. The ELISA titer of our cross-reacting antibodies was ca. 1,000-fold lower than the titer of the PCG-4 antibody or affinitypurified polyclonal antibodies. This low amount of crossreactivity probably explains why previous studies on the antigenic relatedness of the toxins failed to detect any significant cross-reactions between the toxins with polyclonal antibodies. b Toxin A purified by sequential ammonium sulfate precipitation, ionexchange chromatography, and precipitation at pH 5.6 (19 Immunoblot analysis of toxins A and B using the PCG-4 and G-2 MAbs revealed several features about the structures of toxins A and B. Preparations of nondenatured toxin A exhibited a single band, and nondenatured toxin B exhibited one major and two minor bands when stained with Coomassie blue R-250. The PCG-4 MAb reacted only with the toxin A band, whereas the G-2 MAb reacted with the toxin A band and the bands in the toxin B preparation. The estimated molecular weights for the nondenatured toxins, as determined by gel filtration and PAGE, are 440,000 to 500,000 for toxin A and 360,000 to 470,000 for toxin B (26) . These estimates are similar to those reported by Banno et al. (2) , who obtained values of 550,000 to 600,000 and 450,000 to 500,000 for nondenatured toxins A and B, respectively, by gel filtration. When the toxins were denatured with SDS and 2-mercaptoethanol, one major and numerous minor bands were detected in each toxin preparation. The PCG-4 MAb reacted with all of the bands in the toxin A preparation, and the G-2 MAb reacted with the major and some of the minor bands in both toxin preparations. The major band in each 
